Biblio
Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease. Science. 2023;379(6628):179-185.
. Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice. Nat Med. 2023.
Culture of cerebrospinal fluid-contacting neurons from neonatal mouse spinal cord. Cell Tissue Bank. 2023.
. Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice. Circulation. 2023.
. . . .
.
. .
.
. .